Halsey Drug (HDGC) Reports Results For First Quarter 2004
10/19/2005 5:11:24 PM
Halsey Drug Co., Inc. (OTC.BB:HDGC) today announced net income of $680,000 for the quarter ended March 31, 2004 compared to a net loss of $(10,575,000) for the same period in 2003. During the first quarter of 2004 the Company recorded product revenues of $628,000, and gains of $12,401,000 from debt restructuring and $1,754,000 from the divestment of certain non-revenue generating assets. Expenses for the first quarter of 2004 included, among other things, amortization of debt discount and private offering costs of $10,843,000 compared to $5,767,000 for the same period in 2003.
comments powered by